177 related articles for article (PubMed ID: 2996911)
1. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
Swart SS; Maguire M; Wood JK; Barnett DB
Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide.
Jakobs KH; Lasch P; Minuth M; Aktories K; Schultz G
J Biol Chem; 1982 Mar; 257(6):2829-33. PubMed ID: 6277915
[TBL] [Abstract][Full Text] [Related]
3. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
Spence S; Houslay MD
Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
[TBL] [Abstract][Full Text] [Related]
4. Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets.
Willuweit B; Aktories K
Biochem J; 1988 Feb; 249(3):857-63. PubMed ID: 2833229
[TBL] [Abstract][Full Text] [Related]
5. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals.
Swart SS; Pearson D; Wood JK; Barnett DB
Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177
[TBL] [Abstract][Full Text] [Related]
6. Deficient elevation of the cytoplasmic calcium ion concentration by epinephrine in epinephrine-insensitive platelets of patients with myeloproliferative disorders.
Ushikubi F; Okuma M; Ishibashi T; Narumiya S; Uchino H
Am J Hematol; 1990 Feb; 33(2):96-100. PubMed ID: 2154092
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
10. Interactions of agonists with platelet alpha 2-adrenergic receptors.
Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
[TBL] [Abstract][Full Text] [Related]
11. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human platelet adenylate cyclase by epinephrine, prostaglandin E1, and guanine nucleotides. Evidence for separate guanine nucleotide sites mediating stimulation and inhibition.
Steer ML; Wood A
J Biol Chem; 1979 Nov; 254(21):10791-7. PubMed ID: 500609
[TBL] [Abstract][Full Text] [Related]
13. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders.
Swart SS; Pearson D; Wood JK; Barnett DB
Thromb Res; 1984 Mar; 33(5):531-41. PubMed ID: 6326344
[TBL] [Abstract][Full Text] [Related]
15. Differential labeling of platelet alpha 2 adrenoceptors by 3H dihydroergocryptine and 3H yohimbine in patients with myeloproliferative disorders.
Swart SS; Wood JK; Barnett DB
Thromb Res; 1985 Dec; 40(5):623-9. PubMed ID: 3003960
[TBL] [Abstract][Full Text] [Related]
16. Ageing and the alpha 2-adrenergic system of the platelet.
Davis PB; Silski C
Clin Sci (Lond); 1987 Nov; 73(5):507-13. PubMed ID: 2824117
[TBL] [Abstract][Full Text] [Related]
17. Islet-activating protein impairs alpha 2-adrenoceptor-mediated inhibitory regulation of human platelet adenylate cyclase.
Aktories K; Schultz G; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):196-200. PubMed ID: 6140642
[TBL] [Abstract][Full Text] [Related]
18. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
19. Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients.
Karege F; Bovier P; Hilleret H; Gaillard JM
Lancet; 1993 Apr; 341(8851):1029. PubMed ID: 8096917
[No Abstract] [Full Text] [Related]
20. Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
Hamilton CA; Deighton NM; Reid JL
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):534-40. PubMed ID: 2886922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
